"Study Reveals GLP-1 Drugs Like Ozempic and Wegovy Unlikely to Raise Suicidal Ideation Risk"

A large study funded by the National Institutes of Health found that users of the diabetes drug Ozempic and the obesity drug Wegovy had a slightly lower risk of suicidal thoughts compared to those not taking these medications. This research comes after concerns were raised by a European drug safety agency regarding potential links between these drugs and suicidal thoughts. The study, which analyzed electronic health records from over 100 million people, did not find an increased risk of suicidal ideation, providing reassurance about the safety of these drugs. However, the study was observational and further research is needed to establish cause and effect. The findings are timely as the European Medicines Agency continues its investigation into the safety of these drugs.